Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.59 is 45% below its 5-year average of 6.55, near the low end of its 5-year range (1.47–16.94).
As of the fiscal period ended Tuesday, June 30, 2026. 60.71% below its 12-month average of 9.15.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 3.59.
CURRENT RATIO
3.59
CURRENT RATIO AVG TTM
9.15
CURRENT RATIO AVG 3Y
6.58
CURRENT RATIO AVG 5Y
6.55
CURRENT RATIO AVG 10Y
4.63
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-60.71%
CURRENT VS 3Y AVG
-45.35%
CURRENT VS 5Y AVG
-45.17%
CURRENT VS 10Y AVG
-22.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-4.16%
vs the sector median at left
Market Cap
$11.00M
Current Ratio
2.64
TTM Avg
7.53
3Y Avg
7.44
5Y Avg
5.23
Market Cap
$11.02M
Current Ratio
3.69
TTM Avg
5.96
3Y Avg
7.84
5Y Avg
10.45
Market Cap
$11.08M
Current Ratio
8.97
TTM Avg
5.46
3Y Avg
4.04
5Y Avg
3.77
Market Cap
$11.12M
Current Ratio
3.07
TTM Avg
5.09
3Y Avg
9.39
5Y Avg
12.46
Market Cap
$10.45M
Current Ratio
5.63
TTM Avg
4.29
3Y Avg
4.04
5Y Avg
3.65
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioVie Inc. (BIVI) | $10.86M | 3.59 | 9.15 | 6.58 | 6.55 |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | 36.37 | 19.59 | 9.84 | 7.09 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 1.37 | 0.79 | 1.08 | 1.46 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | 2.64 | 7.53 | 7.44 | 5.23 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | 3.69 | 5.96 | 7.84 | 10.45 |
| Pluri Inc. (PLUR)vs › | $10.68M | 0.27 | 0.48 | 3.83 | 4.93 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | 8.97 | 5.46 | 4.04 | 3.77 |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | 3.07 | 5.09 | 9.39 | 12.46 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | 5.63 | 4.29 | 4.04 | 3.65 |
| Caring Brands, Inc. (CABR)vs › | $11.36M | 4.96 | 13.16 | 13.16 | 13.16 |
Current Ratio
3.59
Quick Ratio
3.59
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.59 |
| 2026-03-31 | 9.97 |
| 2025-12-31 | 7.25 |
| 2025-09-30 | 15.83 |
| 2025-06-30 | 9.10 |
| 2025-03-31 | 9.32 |
| 2024-12-31 | 16.94 |
| 2024-09-30 | 2.95 |
| 2024-06-30 | 2.57 |
| 2024-03-31 | 2.45 |
| 2023-12-31 | 1.47 |
| 2023-09-30 | 1.72 |
| 2023-06-30 | 2.35 |
| 2023-03-31 | 2.75 |
| 2022-12-31 | 5.90 |
| 2022-09-30 | 5.27 |
| 2022-06-30 | 4.50 |
| 2022-03-31 | 5.74 |
| 2021-12-31 | 7.01 |
| 2021-09-30 | 16.34 |
| 2021-06-30 | 4.62 |
| 2021-03-31 | 7.98 |
| 2020-12-31 | 36.92 |
| 2020-09-30 | 65.20 |
| 2020-06-30 | 0.02 |
| 2020-03-31 | 0.12 |
| 2019-12-31 | 0.13 |
| 2019-09-30 | 0.07 |
| 2019-06-30 | 1.52 |
| 2019-03-31 | 5.62 |
| 2018-12-31 | 15.55 |
| 2018-09-30 | 11.66 |
| 2018-06-30 | 0.04 |
| 2018-03-31 | 0.03 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.03 |
| 2017-06-30 | 0.01 |
| 2017-03-31 | 0.09 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.01 |
| 2016-06-30 | 0.16 |
| 2016-03-31 | 0.52 |
| 2015-12-31 | 0.62 |
| 2015-09-30 | 0.71 |
| 2015-06-30 | 0.83 |
| 2015-03-31 | 1.00 |
| 2014-12-31 | 1.19 |
| 2014-09-30 | 1.56 |
| 2014-06-30 | 2.06 |
| 2014-03-31 | 143.81 |
| 2013-12-31 | 24.29 |
| 2013-09-30 | 51.57 |
| 2013-06-30 | 0.00 |
